BDX

175.33

1.97% -3.52

Dopo l'orario di chiusura: 175.33

Becton Dickinson Co (BDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BDX Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$178.85

Aprire:

$178.84

Volume 24 ore:

3.13M

Relative Volume:

0.98

Capitalizzazione di mercato:

$50.25B

Reddito:

$20.87B

Utile/perdita netta:

$1.50B

Rapporto P/E:

33.46

EPS:

5.24

Flusso di cassa netto:

$2.59B

1 W Prestazione:

-0.99%

1M Prestazione:

+4.10%

6M Prestazione:

-27.06%

1 anno Prestazione:

-24.01%

Intervallo 1D:

$175.31

$179.58

Intervallo di 1 settimana:

$175.31

$181.60

Portata 52W:

$163.33

$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Nome

Becton Dickinson Co

Settore

Healthcare (1161)

Industria

Medical Instruments & Supplies (59)

Telefono

(201) 847-6800

Indirizzo

ONE BECTON DR, FRANKLIN LAKES

Dipendente

74,000

Cinguettio

@BDandCo

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

BDX's Discussions on Twitter

Confronta BDX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BDX Becton Dickinson Co	175.33	50.76B	20.87B	1.50B	2.59B	5.24
ISRG Intuitive Surgical Inc	516.12	185.10B	8.71B	2.48B	1.75B	6.82
ALC Alcon Inc	87.16	43.19B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	261.07	37.26B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	210.08	16.13B	2.90B	467.20M	306.90M	6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-22	Downgrade	Citigroup	Buy → Neutral
2025-05-02	Downgrade	Goldman	Buy → Neutral
2025-05-02	Downgrade	Piper Sandler	Overweight → Neutral
2025-05-02	Downgrade	Raymond James	Outperform → Mkt Perform
2025-05-01	Downgrade	BofA Securities	Buy → Neutral
2025-05-01	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-05-01	Downgrade	William Blair	Outperform → Mkt Perform
2024-10-01	Aggiornamento	Citigroup	Neutral → Buy
2024-05-30	Iniziato	Goldman	Buy
2023-07-24	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-05-05	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-04-12	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2023-01-03	Aggiornamento	BofA Securities	Neutral → Buy
2022-12-12	Aggiornamento	Citigroup	Sell → Neutral
2022-07-11	Downgrade	Citigroup	Neutral → Sell
2022-06-24	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-03-18	Ripresa	Raymond James	Mkt Perform
2022-03-02	Ripresa	BofA Securities	Neutral
2021-12-08	Downgrade	Piper Sandler	Overweight → Neutral
2021-08-06	Downgrade	JP Morgan	Overweight → Neutral
2021-05-25	Iniziato	Barclays	Equal Weight
2020-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-12-15	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-07-09	Aggiornamento	Barclays	Equal Weight → Overweight
2020-06-01	Ripresa	Goldman	Buy
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-07	Downgrade	Cowen	Outperform → Market Perform
2020-02-07	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2020-02-07	Downgrade	Raymond James	Strong Buy → Outperform
2020-02-06	Downgrade	Cowen	Outperform → Market Perform
2020-01-08	Downgrade	Barclays	Overweight → Equal Weight
2019-05-13	Aggiornamento	Barclays	Equal Weight → Overweight
2018-12-07	Iniziato	Deutsche Bank	Buy
2018-10-16	Iniziato	Barclays	Equal Weight
2018-06-21	Aggiornamento	JP Morgan	Neutral → Overweight
2018-04-10	Aggiornamento	Citigroup	Neutral → Buy
2018-01-19	Ripresa	BofA/Merrill	Buy
2018-01-05	Aggiornamento	Citigroup	Sell → Neutral
2018-01-05	Iniziato	KeyBanc Capital Mkts	Overweight
2018-01-03	Iniziato	Evercore ISI	Outperform
2017-12-29	Reiterato	Deutsche Bank	Buy

Mostra tutto

Becton Dickinson Co Borsa (BDX) Ultime notizie

Jul 20, 2025

The Smartest Dividend Stock to Buy With $1,000 Right Now - The Motley Fool

Jul 20, 2025

Jul 18, 2025

Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation - Yahoo Finance

Jul 18, 2025

Jim Cramer Notes Becton Dickinson Stock Recently “Finished in the Black” - Insider Monkey

Jul 18, 2025

Jul 16, 2025

BD issues voluntary recall on certain Alaris infusion pump modules - MassDevice

Jul 16, 2025

BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $190 - 富途牛牛

Jul 16, 2025

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX) - 富途牛牛

Jul 16, 2025

Jul 15, 2025

Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $196 - 富途牛牛

Jul 15, 2025

BD issues update to recall of Alaris & BD Alaris pump modules - MarketScreener

Jul 15, 2025

BD to spin off biosciences, diagnostics businesses in $17.5B deal (updated) - NJBIZ

Jul 15, 2025

Waters to acquire BD flow cytometry business in a deal valued at $17.5 billion - C&EN

Jul 15, 2025

Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies - MarketScreener

Jul 15, 2025

How Do Investors Really Feel About Becton Dickinson? - 富途牛牛

Jul 15, 2025

Becton Dickinson stock holds steady as TD Cowen maintains $183 price target By Investing.com - Investing.com South Africa

Jul 15, 2025

Becton Dickinson stock holds steady as TD Cowen maintains $183 price target - Investing.com Nigeria

Jul 15, 2025